Clinical Trials Sponsored by Arecor Limited

Total 3053 results

Arecor Limited

Completed

AT278 and NovoRapid® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
Arecor Limited

Completed

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Diabetes Mellitus, Type 2

Austria
Arecor Limited

Completed

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Diabetes Mellitus, Type 1

United States
Arecor Limited

Completed

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Diabetes Mellitus, Type 1

Austria
Aleor Dermaceuticals Limited
Catawba Research, LLC

Completed

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Acne Vulgaris

United States, Belize
ReCor Medical, Inc.

Recruiting

The "Global Paradise System" Registry (GPS Registry)

Hypertension

Germany, Netherlands, Belgium, France, Monaco, Switzerland, United Kingdom
ReCor Medical, Inc.

Completed

REnAL denervatIon by ultraSound Transcatheter Emission (REALISE)

Resistant Hypertension

France
ReCor Medical, Inc.

Active, not recruiting

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension (RADIANCE-II)

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, United Kingdom, Netherlands, France, Ireland, Belgium, Germany, Switzerland
ReCor Medical, Inc.

Active, not recruiting

A Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN)

Vascular Diseases | Hypertension

United States, Netherlands, United Kingdom, Germany, France, Poland, Belgium
ReCor Medical, Inc.

Completed

TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE) (ACHIEVE)

Resistant Hypertension

Germany, Sweden, Netherlands
ReCor Medical, Inc.

Not yet recruiting

Global Paradise System US Post Approval Study (US GPS)

Cardiovascular Diseases | Vascular Diseases | Hypertension
ReCor Medical, Inc.

Active, not recruiting

RADIANCE Continued Access Protocol (RADIANCE CAP)

Cardiovascular Diseases | Vascular Diseases | Hypertension | Hypertension, Resistant to Conventional Therapy

United States
Alector Inc.

Completed

A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101

Healthy

United States
Alector Inc.

Active, not recruiting

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

Frontotemporal Dementia

Canada, United States, Germany, United Kingdom, Italy, Netherlands
Alector Inc.

Terminated

A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS

Amyotrophic Lateral Sclerosis

United States
Alector Inc.

Completed

First in Human Study for Safety and Tolerability of AL003.

Healthy | Alzheimer Disease

United States, Australia
Alector Inc.

Completed

A Phase I Study for Safety and Tolerability of AL002.

Healthy | Alzheimer Disease

United States, United Kingdom, Australia
Alector Inc.

Active, not recruiting

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

Frontotemporal Dementia

Spain, United States, Portugal, United Kingdom, France, Germany, Netherlands, Belgium, Australia, Italy, Turkey, Switzerland, Argentina, Canada, Greece, Sweden
Alector Inc.

Completed

A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

Healthy | Frontotemporal Dementia

United States, Canada, United Kingdom
Medaphor Limited
IntelligentUltrasound Limited

Completed

A Volunteer Study to Collect Imaging Data for the Development of the ntelligentUltrasound Anatomy Guide

Ultrasound Imaging of Anatomical Structures

United Kingdom
Heptares Therapeutics Limited
P1vital Limited

Completed

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Alzheimer's Disease

United Kingdom
pSiVida Limited
pSiOncology Private Limited

Unknown

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Liver Cancer

Singapore
GlaxoSmithKline
Alector Inc.

Recruiting

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease (PROGRESS-AD)

Alzheimer's Disease

United States, Australia, France, Italy, Spain, Germany, Norway, Korea, Republic of, Canada, Finland, Sweden, Taiwan, Argentina, Turkey, Netherlands, United Kingdom
AtaCor Medical, Inc.

Recruiting

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

Conduction Defect

Croatia, Czechia
AtaCor Medical, Inc.

Completed

Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrythmia

Paraguay
PrECOG, LLC.
Takeda

Completed

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma (PrE0404)

Mantle-Cell Lymphoma

United States
PrECOG, LLC.
AstraZeneca

Completed

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma (PrE0505)

Mesothelioma | Pleural Mesothelioma

United States
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study (STEP IV)

Conduction Defect

Paraguay
AtaCor Medical, Inc.

Completed

AtaCor Subcostal Temporary Extravascular Pacing III Study (STEP III)

Conduction Defect

New Zealand, Paraguay, Czechia
PrECOG, LLC.
Pfizer

Terminated

NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma (PrE0801)

Renal Cell Carcinoma

United States
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extracardiac Pacing II Study (STEP II)

Conduction Defect

New Zealand, Paraguay
PrECOG, LLC.
AstraZeneca

Completed

Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer

Lung Cancer | Non Small Cell Lung Cancer

United States
Paracor Medical, Inc

Terminated

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure (PEERLESS-HF)

Heart Failure, Congestive

United States
Alector Inc.
GlaxoSmithKline

Enrolling by invitation

Continuation Study for Latozinemab

Neurodegenerative Diseases

Canada, United States, Belgium, France, Spain, Portugal, Germany, Italy, Netherlands, Sweden, United Kingdom
Alector Inc.
AbbVie

Active, not recruiting

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (INVOKE-2)

Alzheimer Disease

United States, Spain, France, Germany, Australia, Canada, Poland, Italy, Argentina, Netherlands, United Kingdom, New Zealand
AtaCor Medical, Inc.

Completed

Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study (PASS PULL)

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmia

Paraguay
PrECOG, LLC.
Novartis

Completed

Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI (PrE0102)

Metastatic Breast Cancer

United States
Exonate Limited
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Diabetic Macular Edema

Australia
Alector Inc.
AbbVie

Recruiting

A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

Alzheimer's Disease

Australia, Spain, United States, Italy, Canada, Poland, United Kingdom, Germany
AtaCor Medical, Inc.

Recruiting

Subcostal Temporary Extravascular Pacing V Study (STEP V)

Conduction Defect

Paraguay
AtaCor Medical, Inc.

Completed

Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study (SECURE EV)

Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrhythmia

Paraguay
AtaCor Medical, Inc.

Completed

Subcostal Temporary Extracardiac Pacing Study (STEP)

Conduction Defect

Paraguay
PrECOG, LLC.
Celgene

Terminated

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction (PrE1003)

Multiple Myeloma | Plasma Cell Neoplasm

United States
Paracor Medical, Inc

Terminated

Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial (PEERLESS-HF)

Heart Failure

United States, Canada
Clinuvel Europe Limited

Recruiting

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Xeroderma Pigmentosum

Germany
Medibio Limited

Recruiting

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) (SAMDE)

Depressive Disorder | Depression | Depressive Disorder, Major | Depressive Episode | Depression Mild

United States
CroiValve Limited

Recruiting

A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation (TANDEM I)

Tricuspid Regurgitation

Poland
Novoic Limited

Not yet recruiting

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping (EARS)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer's Disease (Incl Subtypes)
BicycleTx Limited

Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Carcinoma, Non-Small-Cell Lung | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Ovarian Neoplasm | Urinary Bladder Neoplasm

United States, United Kingdom, France, Spain, Italy, Canada
BicycleTx Limited

Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Head and Neck Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Solid Tumor Historically Known for High EphA2 Expression | Urothelial Cancer | Gastric/Upper Gastrointestinal Cancer

United States, Belgium, Korea, Republic of, Spain, United Kingdom

Clinical Trials Sponsored by Arecor Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations